ResearchMoz

Global Markets Direct Market Research Reports

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

List of reports from Global Markets Direct

Displaying 201 to 230 (of 2353 records)
Pages: « Prev  2 3 4 5 6 7 8 9 10 11   Next »
Diabetic Retinopathy Pipeline Review, H1 2013
Mar 2013  
Diabetic Retinopathy Pipeline Review, H1 2013 Summary Global Markets Directs, 'Diabetic Retinopathy Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Retinopathy, complete with latest updates, and special features on late-stage and discontinued...
$2000
Overactive Bladder Pipeline Review, H1 2013
Mar 2013  
Overactive Bladder Pipeline Review, H1 2013 Summary Global Markets Directs, 'Overactive Bladder Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Overactive Bladder, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
B-Cell Lymphomas Pipeline Review, H1 2013
Mar 2013  
B-Cell Lymphomas Pipeline Review, H1 2013 Summary Global Markets Directs, 'B-Cell Lymphomas Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for B-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Cancer Pain Pipeline Review, H1 2013
Mar 2013  
Cancer Pain Pipeline Review, H1 2013 Summary Global Markets Directs, 'Cancer Pain Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cancer Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Human Papillomavirus Infections Pipeline Review, H1 2013
Mar 2013  
Human Papillomavirus Infections Pipeline Review, H1 2013 Summary Global Markets Directs, 'Human Papillomavirus Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Human Papillomavirus Infections, complete with latest updates, and special features on...
$2000
Diabetic Nephropathy Pipeline Review, H1 2013
Mar 2013  
Diabetic Nephropathy Pipeline Review, H1 2013 Summary Global Markets Directs, 'Diabetic Nephropathy Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Nephropathy, complete with latest updates, and special features on late-stage and discontinued...
$2000
Diabetic Foot Ulcers Pipeline Review, H1 2013
Mar 2013  
Diabetic Foot Ulcers Pipeline Review, H1 2013 Summary Global Markets Directs, 'Diabetic Foot Ulcers Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Foot Ulcers, complete with latest updates, and special features on late-stage and discontinued...
$2000
Hypercholesterolemia Pipeline Review, H1 2013
Mar 2013  
Hypercholesterolemia Pipeline Review, H1 2013 Summary Global Markets Directs, 'Hypercholesterolemia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Hypercholesterolemia, complete with latest updates, and special features on late-stage and discontinued...
$2000
Ocular Hypertension Pipeline Review, H1 2013
Mar 2013  
Ocular Hypertension Pipeline Review, H1 2013 Summary Global Markets Directs, 'Ocular Hypertension Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ocular Hypertension, complete with latest updates, and special features on late-stage and discontinued projects....
$2000
Herpes Simplex Infections Pipeline Review, H1 2013
Mar 2013  
Herpes Simplex Infections Pipeline Review, H1 2013 Summary Global Markets Directs, 'Herpes Simplex Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Herpes Simplex Infections, complete with latest updates, and special features on late-stage and...
$2000
Neutropenia Pipeline Review, H1 2013
Mar 2013  
Neutropenia Pipeline Review, H1 2013 Summary Global Markets Directs, 'Neutropenia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Neutropenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Head And Neck Cancer Squamous Cell Carcinoma Pipeline Review, H1 2013
Mar 2013  
Head And Neck Cancer Squamous Cell Carcinoma Pipeline Review, H1 2013 Summary Global Markets Directs, 'Head And Neck Cancer Squamous Cell Carcinoma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma, complete with...
$2000
Diarrhea Pipeline Review, H1 2013
Mar 2013  
Diarrhea Pipeline Review, H1 2013 Summary Global Markets Directs, 'Diarrhea Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diarrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Kidney Transplantation Pipeline Review, H1 2013
Mar 2013  
Kidney Transplantation Pipeline Review, H1 2013 Summary Global Markets Directs, 'Kidney Transplantation Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Kidney Transplantation, complete with latest updates, and special features on late-stage and discontinued...
$2000
Peritoneal Tumor Pipeline Review, H1 2013
Mar 2013  
Peritoneal Tumor Pipeline Review, H1 2013 Summary Global Markets Directs, 'Peritoneal Tumor Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Peritoneal Tumor, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Onychomycosis (Tinea Unguium) Pipeline Review, H1 2013
Mar 2013  
Onychomycosis (Tinea Unguium) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Onychomycosis (Tinea Unguium) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with latest updates, and special features on...
$2000
Postherpetic Neuralgia Pipeline Review, H1 2013
Mar 2013  
Postherpetic Neuralgia Pipeline Review, H1 2013 Summary Global Markets Directs, 'Postherpetic Neuralgia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Postherpetic Neuralgia, complete with latest updates, and special features on late-stage and discontinued...
$2000
Renal Anemia Pipeline Review, H1 2013
Mar 2013  
Renal Anemia Pipeline Review, H1 2013 Summary Global Markets Directs, 'Renal Anemia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Renal Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Growth Hormone Deficiency Pipeline Review, H1 2013
Mar 2013  
Growth Hormone Deficiency Pipeline Review, H1 2013 Summary Global Markets Directs, 'Growth Hormone Deficiency Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and...
$2000
Candidiasis Pipeline Review, H1 2013
Mar 2013  
Candidiasis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Candidiasis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Candidiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Cough Pipeline Review, H1 2013
Mar 2013  
Cough Pipeline Review, H1 2013 Summary Global Markets Directs, 'Cough Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cough, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in...
$2000
Relapsing Remitting Multiple Sclerosis (RRMS) Pipeline Review, H1 2013
Mar 2013  
Relapsing Remitting Multiple Sclerosis (RRMS) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Relapsing Remitting Multiple Sclerosis (RRMS) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with...
$2000
Dyskinesia Pipeline Review, H1 2013
Mar 2013  
Dyskinesia Pipeline Review, H1 2013 Summary Global Markets Directs, 'Dyskinesia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Dyskinesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Lupus Nephritis Pipeline Review, H1 2013
Mar 2013  
Lupus Nephritis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Lupus Nephritis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Lupus Nephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Metabolic Disorders Pipeline Review, H1 2013
Mar 2013  
Metabolic Disorders Pipeline Review, H1 2013 Summary Global Markets Directs, 'Metabolic Disorders Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metabolic Disorders, complete with latest updates, and special features on late-stage and discontinued projects....
$2000
Opium (Opioid) Addiction Pipeline Review, H1 2013
Mar 2013  
Opium (Opioid) Addiction Pipeline Review, H1 2013 Summary Global Markets Directs, 'Opium (Opioid) Addiction Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Opium (Opioid) Addiction, complete with latest updates, and special features on late-stage and...
$2000
Actinic Keratosis Pipeline Review, H1 2013
Mar 2013  
Actinic Keratosis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Actinic Keratosis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Actinic Keratosis, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Pertussis Pipeline Review, H1 2013
Mar 2013  
Pertussis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Pertussis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pertussis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Smallpox Pipeline Review, H1 2013
Mar 2013  
Smallpox Pipeline Review, H1 2013 Summary Global Markets Directs, 'Smallpox Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Smallpox, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
Tetanus Pipeline Review, H1 2013
Mar 2013  
Tetanus Pipeline Review, H1 2013 Summary Global Markets Directs, 'Tetanus Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Tetanus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
 
Displaying 201 to 230 (of 2353 records)
Pages: « Prev  2 3 4 5 6 7 8 9 10 11   Next »